Where is Voy located?

Voy is headquartered in London, United Kingdom. It is registered at 2 Underwood Row, London, United Kingdom, N1 7LQ.

How many employees does Voy have?

As of Sep 30, 2026, the latest employee count at Voy is 510.

What is the annual revenue of Voy?

Annual revenue of Voy is between £100M and £500M as on Dec 31, 2025

Where does Voy rank among its competitors?

Voy ranks 4th amongst 53 active competitors, of which 7 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was YStory, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of Voy?

Voy's top competitors include Balance, PRICKLYPEAR.IO and Vira Health. Among them, YStory secured the most recent funding round in April, 2026.

Voy - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Provider of online programmes for weight loss, hair loss, and menopause. The company offers clinically proven treatments and diagnostics, including at-home blood tests. It provides access to clinicians and support via an application, phone, or email. The company offers support powered by artificial intelligence.

Website: www.joinvoy.com/
Social
Email ID: *****@joinvoy.com
Phone Number: +44 **********
Registered Address: 2 Underwood Row, London, United Kingdom, N1 7LQ

Key Metrics

Founded Year

2022

Location

London, United Kingdom

Stage

Funding Raised

Investors

Acurio Ventures

Ranked

4^th among 53 active competitors

Annual Revenue

£100M - £500M as on Dec 31, 2025

Employee Count

510 as on Sep 30, 2026

Similar Companies

Balance & 53 more

View Voy's full profile

Voy is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MENWELL LIMITED CIN: 11476975 , United Kingdom, Active	Jul 22, 2018	£100M - £500M (As on Dec 31, 2025)	128 (As on Dec 31, 2023)

Voy is a funded company. Voy has 1 institutional investor.

View details of Voy's funding rounds and investors

Voy's employee count trend

Voy has 510 employees as of Sep 26. Here is Voy's employee count trend over the years:

Uncover Voy's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Voy include Balance, PRICKLYPEAR.IO and Vira Health. Here is the list of Top 10 competitors of Voy, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Balance 2020, Manchester (United Kingdom), Unfunded	Provider of an application for menopause support	-	-	52/100
2nd	PRICKLYPEAR.IO 2018, Phoenix (United States), Seed	Developer of voice analysis software for monitoring hormonal health changes	$850K	Bayless HealthVentures, Arizona Venture Development ... & 2 others	46/100
3rd	Vira Health 2019, London (United Kingdom), Series A	Provider of software solutions for menopause & fertility monitoring	$15.9M	MMC Ventures, LocalGlobe & 24 others	43/100
4th	Voy 2022, London (United Kingdom), Funding Raised	Provider of online programmes for weight loss, hair loss, and menopause	-	Acurio Ventures	39/100
5th	Lisa Health 2014, Oakland (United States), Funding Raised	Provider of an online community platform for women health	-	SRI Ventures, Synetro Group & 1 others	34/100
6th	Elda Health 2020, Bengaluru (India), Seed	Provider of employee health benefits platform for menopause assessments and consultation	$1.74M	Orios Venture Partners, Avaana Capital Advisors ... & 9 others	34/100
7th	Femilog 2020, Copenhagen (Denmark), Funding Raised	Mobile-based application for menopause health tracking	-	-	32/100
8th	YStory 2023, Tokyo (Japan), Seed	Developer of digital health applications for managing female hormonal changes	-	Kyoto University Innovation Capital, ANRI ... & 4 others	28/100
9th	YStory 2023, Bunkyo (Japan), Seed	Mobile application to support women with menopause	-	ANRI, DEEPCORE	27/100
10th	Midday 2020, Oakland (United States), Funding Raised	Mobile application for the management of menopause	-	SRI	25/100